✦ LIBER ✦

Long-Term Outcomes of Alemtuzumab-Based Reduced-Intensity Conditioned Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Secondary to Myelodysplastic Syndrome

✍ Scribed by Potter, Victoria T.; Krishnamurthy, Pramila; Barber, Linda D.; Lim, ZiYi; Kenyon, Michelle; Ireland, Robin M.; de Lavallade, Hugues; Dhouri, Abdel; Marsh, Judith C.W.; Marcus, Robert; Devereux, Stephen; Ho, Aloysius; Pagliuca, Antonio; Mufti, Ghulam J.

Book ID: 122140100
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 595 KB
Volume: 20
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2013.10.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long Term Outcomes for Alemtuzumab Based

Long Term Outcomes for Alemtuzumab Based Reduced Intensity Conditioning Transplant for Myelodysplastic Syndromes and Acute Myeloid Leukaemia

✍ V.T. Potter; P. Krishnamurthy; V.J. Tindell; Z. Lim; R. Ireland; J.C. Marsh; A. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Outcomes of alemtuzumab-based reduced in

Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes

✍ Zi Yi Lim; Aloysius Y. L. Ho; Wendy Ingram; Michelle Kenyon; Laurence Pearce; Ba 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 572 KB

Cost and effectiveness of reduced-intens

Cost and effectiveness of reduced-intensity and conventional allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome

✍ Osamu Imataki; Takeshi Kamioka; Takashi Fukuda; Ryuji Tanosaki; Yoichi Takaue 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 163 KB

Impact of Conditioning Regimen Intensity

Impact of Conditioning Regimen Intensity on Outcome of Allogeneic Hematopoietic Cell Transplantation for Advanced Acute Myelogenous Leukemia and Myelodysplastic Syndrome

✍ Edwin P. Alyea; Haesook T. Kim; Vincent Ho; Corey Cutler; Daniel J. DeAngelo; Ri 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Reduced-intensity allogeneic hematopoiet

Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning

✍ Ho, A. Y. L. 📂 Article 📅 2004 🏛 American Society of Hematology 🌐 English ⚖ 90 KB

Allogeneic Hematopoietic Stem Cell Trans

Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of High-Risk Acute Myelogenous Leukemia and Myelodysplastic Syndrome Using Reduced-Intensity Conditioning with Fludarabine and Melphalan

✍ Betul Oran; Sergio Giralt; Rima Saliba; Chitra Hosing; Uday Popat; Issa Khouri; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 387 KB